메뉴 건너뛰기




Volumn 55, Issue 12, 2000, Pages 1785-1789

Selegiline and mortality in subjects with Parkinson's disease: A longitudinal community study

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CARDIOVASCULAR AGENT; LEVODOPA; NEUROLEPTIC AGENT; SELEGILINE;

EID: 0034719031     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.12.1785     Document Type: Article
Times cited : (48)

References (17)
  • 8
    • 9044227267 scopus 로고
    • Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease
    • (1995) BMJ , vol.311 , pp. 1602-1607
    • Lees, A.L.1
  • 11
    • 0031893241 scopus 로고    scopus 로고
    • Mortality in DATATOP: A multicenter trial in early Parkinson's disease
    • (1998) Ann Neurol , vol.43 , pp. 318-325
  • 14
    • 0006207447 scopus 로고    scopus 로고
    • British National Formulary. British Medical Association and Royal Pharmaceutical Society for Great Britain, London
    • (1996)
  • 17
    • 85037422537 scopus 로고    scopus 로고
    • Does selegiline increase mortality?
    • Proceedings of the fifth annual meeting of the European Society of Pharmacovigilance; Berlin; September. Abstract
    • (1997) , vol.44
    • Evans, S.J.W.1    Sivananthan, T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.